Crossref
Delayed Elimination of High-Dose Methotrexate: Risk Factors
JPDM · 01.12.2023 · 6 (1)
DOI: 10.17303/jpdm.2023.6.102 ↗Kurz gefasst
Fachartikel in der Zeitschrift JPDM, online erschienen am 04.12.2023. Verfasst von Bouraoui Hajer.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Hajer, B. (2023). Delayed Elimination of High-Dose Methotrexate: Risk Factors. JPDM, 6(1). https://doi.org/10.17303/jpdm.2023.6.102
Vancouver
Hajer B. Delayed Elimination of High-Dose Methotrexate: Risk Factors. JPDM. 2023;6(1). doi:10.17303/jpdm.2023.6.102
BibTeX
@article{Hajer2023,
author = {Hajer, Bouraoui},
title = {Delayed Elimination of High-Dose Methotrexate: Risk Factors},
journal = {JPDM},
year = {2023},
volume = {6},
number = {1},
doi = {10.17303/jpdm.2023.6.102}
}
EUVIMED